Common antibiotic linked to risk of sudden death, study finds

Share this article:
An antibiotic frequently used to treat pneumonia and bronchitis is linked to a higher risk of sudden death in adults, particularly those with heart conditions, a new study reveals. 

Azithromycin, which is frequently referred to as a “Z-Pak,” was generally believed to be safer than antibiotics such as erythromycin and clarithromycin. Previous studies have linked erythromycin with a higher risk for heart attack. 

However, when researchers from Vanderbilt University calculated the rate of deaths per million courses of treatment, based on the medical records of about 540,000 Medicaid recipients, azithromycin had 64.6 deaths per million courses. Amoxicillin was much lower, with a rate of 21.8, according to the study.

Individuals with conditions such as heart failure, or who have undergone a bypass, are considered to be at a higher risk for death, the New York Times reported. 

The study was published May 17 in the New England Journal of Medicine.

Share this article:

More in News

CMS expands therapy payment research

The government is expanding its research into alternative therapy payments, to consider more holistic changes to the way Medicare reimburses skilled nursing facilities, the Centers for Medicare & Medicaid Services announced Tuesday.

CDC tightens Ebola guidelines for healthcare workers

The Centers for Disease Control and Prevention has issued more stringent guidelines for how healthcare workers should interact with Ebola patients, following an outcry from nurses and other professionals.

Nonprofit providers face alarming market forces, must rally, LeadingAge chairman says

Nonprofit providers face alarming market forces, must rally, ...

Nonprofit long-term care providers must work together to address alarming trends, or their market share could plummet and the sector as a whole could falter, LeadingAge Chairman David Gehm told ...